Concepedia

Thomas Haws

TH

Statistics

Publications

3

Citations

221

H-Index

3

Active since

2014

Affiliations

GlaxoSmithKline (United States)(Current)

Thomas Haws is an author at GlaxoSmithKline (United States) specializing in health sciences, medicine, and cardiovascular disease.

Top concepts

Publications per year

2014–2019

3

Publications

3

Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction

John J. Lepore, Eric J. Olson, Laura A. Demopoulos et al. · JACC Heart Failure · 2016 · 164 citations

, , +13

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

Eric J. Olson, Laura A. Demopoulos, Thomas Haws et al. · Vascular Medicine · 2014 · 47 citations

A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia

Eric J. Olson, Kelly M. Mahar, Thomas Haws et al. · Clinical Pharmacology in Drug Development · 2019 · 10 citations

, , +12

1–3 of 3